Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1965 1
1966 1
1969 1
1972 1
1973 1
1975 4
1976 4
1978 3
1979 1
1980 6
1981 3
1982 1
1983 3
1984 6
1985 2
1986 2
1987 7
1988 5
1989 4
1990 3
1991 8
1992 9
1993 8
1994 4
1995 1
1996 9
1997 10
1998 16
1999 8
2000 9
2001 7
2002 16
2003 9
2004 15
2005 12
2006 9
2007 13
2008 11
2009 16
2010 19
2011 17
2012 23
2013 22
2014 40
2015 27
2016 33
2017 30
2018 43
2019 33
2020 38
2021 38
2022 31
2023 34
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

639 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20Hub, A1lek
Page 1
C3 Glomerulopathy.
Martín B, Smith RJH. Martín B, et al. 2007 Jul 20 [updated 2018 Apr 5]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2007 Jul 20 [updated 2018 Apr 5]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 20301598 Free Books & Documents. Review.
CLINICAL CHARACTERISTICS: C3 glomerulopathy (C3G) is a complex ultra-rare complement-mediated renal disease caused by uncontrolled activation of the complement alternative pathway (AP) in the fluid phase (as opposed to cell surface) that is rarely inherited in a simple men …
CLINICAL CHARACTERISTICS: C3 glomerulopathy (C3G) is a complex ultra-rare complement-mediated renal disease caused by uncontrolled ac …
Influenza-associated thrombotic microangiopathies.
Bitzan M, Zieg J. Bitzan M, et al. Pediatr Nephrol. 2018 Nov;33(11):2009-2025. doi: 10.1007/s00467-017-3783-4. Epub 2017 Sep 7. Pediatr Nephrol. 2018. PMID: 28884355 Free PMC article. Review.
Oligoanuria was documented in 81% and neurological involvement in 40% of patients. Serum C3 was reduced in 5 out of 14 patients (36%); Coombs test was negative in 7 out of 7 and elevated fibrin/fibrinogen degradation products were documented in 6 out of 8 patients. Pathoge …
Oligoanuria was documented in 81% and neurological involvement in 40% of patients. Serum C3 was reduced in 5 out of 14 patients (36%) …
Novel Therapeutic Targets for Managing Dyslipidemia.
Sathiyakumar V, Kapoor K, Jones SR, Banach M, Martin SS, Toth PP. Sathiyakumar V, et al. Trends Pharmacol Sci. 2018 Aug;39(8):733-747. doi: 10.1016/j.tips.2018.06.001. Epub 2018 Jun 30. Trends Pharmacol Sci. 2018. PMID: 29970260 Review.
However, based on findings from Mendelian studies and genetic sequencing in prospective longitudinal cohorts from around the world, novel therapeutic targets regulating lipid and lipoprotein metabolism, such as apoprotein C3, angiopoietin-like proteins 3 and 4, and lipopro …
However, based on findings from Mendelian studies and genetic sequencing in prospective longitudinal cohorts from around the world, novel th …
Intracellular complement activation-An alarm raising mechanism?
Reichhardt MP, Meri S. Reichhardt MP, et al. Semin Immunol. 2018 Aug;38:54-62. doi: 10.1016/j.smim.2018.03.003. Epub 2018 Apr 7. Semin Immunol. 2018. PMID: 29631809 Review.
In addition to the known synthetic machinery in the liver and by macrophages, many other cell types, including lymphocytes, adipocytes and epithelial cells produce selected complement components. Activation of e.g. C3 and C5 inside cells may have multiple effects ranging f …
In addition to the known synthetic machinery in the liver and by macrophages, many other cell types, including lymphocytes, adipocytes and e …
Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations.
Bodó I, Amine I, Boban A, Bumbea H, Kulagin A, Lukina E, Piekarska A, Zupan IP, Sokol J, Windyga J, Cermak J. Bodó I, et al. Adv Ther. 2023 Jun;40(6):2752-2772. doi: 10.1007/s12325-023-02510-4. Epub 2023 Apr 18. Adv Ther. 2023. PMID: 37072660 Free PMC article.
Three complement inhibitors are approved by the European Medicines Agency as targeted therapy for PNH: eculizumab and ravulizumab, two humanized monoclonal antibodies targeting the same complement 5 (C5) epitope, approved in 2007 and 2019, respectively, and the more recently appr …
Three complement inhibitors are approved by the European Medicines Agency as targeted therapy for PNH: eculizumab and ravulizumab, two human …
Renin and renin blockade have no role in complement activity.
Zhang Y, Martin B, Spies MA, Roberts SM, Nott J, Goodfellow RX, Nelson AFM, Blain SJ, Redondo E, Nester CM, Smith RJH. Zhang Y, et al. Kidney Int. 2024 Feb;105(2):328-337. doi: 10.1016/j.kint.2023.11.005. Epub 2023 Nov 25. Kidney Int. 2024. PMID: 38008161 Free article.
Recent studies have suggested that renin may also cleave complement component C3 to activate complement or contribute to its dysregulation. Typically, C3 is cleaved by C3 convertase, a serine protease that uses the hydroxyl group of a serine residue as a nucl …
Recent studies have suggested that renin may also cleave complement component C3 to activate complement or contribute to its dysregul …
Microwave Synthesis of Visible-Light-Activated g-C3N4/TiO2 Photocatalysts.
Matias ML, Reis-Machado AS, Rodrigues J, Calmeiro T, Deuermeier J, Pimentel A, Fortunato E, Martins R, Nunes D. Matias ML, et al. Nanomaterials (Basel). 2023 Mar 17;13(6):1090. doi: 10.3390/nano13061090. Nanomaterials (Basel). 2023. PMID: 36985984 Free PMC article.
Fragmentation pathways during Maillard-induced carbohydrate degradation.
Smuda M, Glomb MA. Smuda M, et al. J Agric Food Chem. 2013 Oct 30;61(43):10198-208. doi: 10.1021/jf305117s. Epub 2013 Feb 20. J Agric Food Chem. 2013. PMID: 23425499 Review.
A multitude of Maillard dicarbonyls covering the range of the intact carbon backbone down to C3 and C2 fragments were detected in several carbohydrate systems, for example, in glucose, maltose, or ascorbic acid reactions. ...
A multitude of Maillard dicarbonyls covering the range of the intact carbon backbone down to C3 and C2 fragments were detected in sev …
639 results